Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 126

    1.

    ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature.

    Alivernini S, Laria A, Gremese E, Zoli A, Ferraccioli G.

    Arthritis Res Ther. 2009;11(6):R163. Epub 2009 Nov 3. Review.

    PMID:
    19886983
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.

    Malottki K, Barton P, Tsourapas A, Uthman AO, Liu Z, Routh K, Connock M, Jobanputra P, Moore D, Fry-Smith A, Chen YF.

    Health Technol Assess. 2011 Mar;15(14):1-278. Review.

    PMID:
    21439251
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.

    Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT, Kollerup G, Linde L, Lindegaard HM, Poulsen UE, Schlemmer A, Jensen DV, Jensen S, Hostenkamp G, Østergaard M; All Departments of Rheumatology in Denmark.

    Arthritis Rheum. 2010 Jan;62(1):22-32.

    PMID:
    20039405
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

    Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

    Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

    PMID:
    17049139
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Tumour necrosis factor-alpha blockers in rheumatoid arthritis: review of the clinical experience.

    Richard-Miceli C, Dougados M.

    BioDrugs. 2001;15(4):251-9. Review.

    PMID:
    11437690
    [PubMed - indexed for MEDLINE]
    7.

    Biological disease modifying anti-rheumatic drugs.

    Cranwell-Bruce LA.

    Medsurg Nurs. 2011 May-Jun;20(3):147-50. No abstract available.

    PMID:
    21786492
    [PubMed - indexed for MEDLINE]
    8.

    B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.

    Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.

    Arthritis Rheum. 2007 May;56(5):1417-23.

    PMID:
    17469098
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.

    Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, Massara A, Nacci F, Secchi ME, Manganelli S, Salaffi F, Bambara ML, Bombardieri S, Cutolo M, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Grassi W, Lapadula G, Cerinic MM, Montecucco C, Trotta F, Triolo G, Valentini G, Valesini G, Ferraccioli GF; GISEA group.

    J Rheumatol. 2007 Aug;34(8):1670-3. Epub 2007 Jul 1. Erratum in: J Rheumatol. 2007 Sep;34(9):1947.

    PMID:
    17611987
    [PubMed - indexed for MEDLINE]
    10.

    [The efficacy of the three available anti-tumour necrosis factor therapies in patients with rheumatoid arthritis. A meta-analytic literature review--secondary publication].

    Christensen R, Kristensen LE, Geborek P, Danneskiold-Samsøe B, Saxne T, Bliddal H.

    Ugeskr Laeger. 2009 Jun 22;171(26):2192-4. Review. Danish.

    PMID:
    19678436
    [PubMed - indexed for MEDLINE]
    11.

    Trials reveal promising options for treating juvenile rheumatoid arthritis.

    Hampton T.

    JAMA. 2008 Jan 2;299(1):27-8. No abstract available.

    PMID:
    18167400
    [PubMed - indexed for MEDLINE]
    12.

    [Rituximab in patients with rheumatoid arthritis: systematic review].

    Brodszky V, Czirják L, Géher P, Hodinka L, Kárpáti K, Péntek M, Poór G, Szekanecz Z, Gulácsi L.

    Orv Hetil. 2007 Oct 7;148(40):1883-93. Review. Hungarian.

    PMID:
    17905683
    [PubMed - indexed for MEDLINE]
    13.

    [Answers to questions on rheumatoid arthritis from Practice No. 23].

    Mertens JC, Kaplan V, Ciurea A.

    Praxis (Bern 1994). 2008 Dec 3;97(24):1309. German. No abstract available.

    PMID:
    19048512
    [PubMed - indexed for MEDLINE]
    14.

    Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.

    Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU; GO-AFTER study investigators.

    Lancet. 2009 Jul 18;374(9685):210-21. Epub 2009 Jun 26. Erratum in: Lancet. 2009 Oct 24;374(9699):1422.

    PMID:
    19560810
    [PubMed - indexed for MEDLINE]
    15.

    Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review.

    Rubbert-Roth A, Finckh A.

    Arthritis Res Ther. 2009;11 Suppl 1:S1. Epub 2009 Apr 6. Review.

    PMID:
    19368701
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis.

    Kastbom A, Bratt J, Ernestam S, Lampa J, Padyukov L, Söderkvist P, Skogh T.

    Arthritis Rheum. 2007 Feb;56(2):448-52.

    PMID:
    17265480
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety.

    Alonso-Ruiz A, Pijoan JI, Ansuategui E, Urkaregi A, Calabozo M, Quintana A.

    BMC Musculoskelet Disord. 2008 Apr 17;9:52. Review.

    PMID:
    18419803
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.

    Jobanputra P, Barton P, Bryan S, Burls A.

    Health Technol Assess. 2002;6(21):1-110. Review. No abstract available.

    PMID:
    12387732
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis.

    Geborek P, Saxne T.

    Rheumatology (Oxford). 2000 Oct;39(10):1159-61. No abstract available.

    PMID:
    11035144
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.

    Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F, Stoyanova-Scholz M, Wassenberg S, Kapelle A, Listing J.

    Arthritis Rheum. 2006 Nov;54(11):3399-407.

    PMID:
    17075823
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk